Similar to observations in experimental studies demonstrating SGLT2 inhibition effects on intraglomerular hypertension and hyperfiltration, these agents reduce inulin-based measures of hyperfiltration and hyperperfusion in human mechanistic studies [11]. Here, SLC5A2 is linked to Hypertension.